HCG Vs Enclomiphene: What’s The Difference For Men?

Written by the UPGUYS Editorial Team

Published on August 12, 2026

Men exploring alternatives or complementary approaches to testosterone replacement therapy (TRT) in Canada may come across two options: human chorionic gonadotropin (hCG) and enclomiphene.

Both can support the body's own testosterone production, but they work in different ways. Enclomiphene acts higher in the hormonal signalling pathway by encouraging the brain and pituitary gland to increase signals to the testes. hCG acts more directly on the testes by mimicking the activity of luteinizing hormone (LH).

That difference can matter when considering testosterone levels, fertility, sperm production, hormone testing and how treatment is administered. Neither option is automatically better for every man, and the choice depends on the underlying cause of low testosterone, fertility goals and individual health factors.

Topics covered in this article:

What Is hCG?

Human chorionic gonadotropin, or hCG, is a hormone-based treatment that can stimulate the testes to produce testosterone.

In men, hCG acts similarly to luteinizing hormone (LH). LH normally travels from the pituitary gland to the testes, where it activates Leydig cells responsible for producing testosterone. hCG can bind to the same receptors and provide a similar signal, stimulating testosterone production.

Unlike enclomiphene, which works by increasing the body's own hormonal signals from higher in the hypothalamic-pituitary-testicular pathway, hCG acts more directly at the level of the testes.

hCG is administered by injection. Health Canada's Drug Product Database currently lists prescription chorionic gonadotropin products for injection in Canada.

Because hCG stimulates testicular testosterone production rather than supplying testosterone directly, it may be considered in certain men where maintaining testicular function or fertility is an important part of the treatment plan.

What Is Enclomiphene?

Enclomiphene is a selective estrogen receptor modulator (SERM) that can stimulate the body to produce more of its own testosterone. Unlike hCG, which acts directly at the testes, enclomiphene works higher in the hormonal signalling pathway.

It reduces estrogen-related negative feedback at the hypothalamic-pituitary level. This can encourage the pituitary gland to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

LH then signals the Leydig cells in the testes to produce testosterone, while FSH plays an important role in supporting sperm production.

Clinical trials in men with secondary hypogonadism have shown that enclomiphene can increase testosterone, LH and FSH while maintaining sperm concentrations, which distinguishes it from treatments that directly replace testosterone and may suppress these signals.

Enclomiphene is taken orally, making its administration different from injectable hCG. Whether it is appropriate depends on the underlying cause of low testosterone, fertility goals and how well the hypothalamic-pituitary-testicular axis is functioning.

How Do hCG and Enclomiphene Work Differently?

hCG and enclomiphene can both support testosterone production, but they act at different points in the hormonal signalling pathway.

A simplified version of the pathway looks like this:

Brain → pituitary gland → LH and FSH → testes

Enclomiphene works upstream. It reduces estrogen-related negative feedback at the hypothalamic-pituitary level, which can increase the body’s own production of LH and FSH. These hormones then signal the testes to produce testosterone and support sperm production.

hCG works more directly at the testes. It acts similarly to LH by binding to LH receptors on Leydig cells, stimulating testosterone production without relying on the pituitary gland to release more LH.

This difference is important because enclomiphene aims to stimulate the body’s natural signalling pathway, while hCG provides an LH-like signal directly to the testes.

hCG vs Enclomiphene at a Glance

The main difference is where they act. hCG provides an LH-like signal directly to the testes, while enclomiphene encourages the brain and pituitary to produce more of the body's own LH and FSH. Neither approach is universally better, and the choice depends on the cause of low testosterone, fertility goals and individual response.

Which Raises Testosterone More?

There is no clear universal winner between hCG and enclomiphene for raising testosterone. How strongly testosterone increases can depend on the underlying cause of low testosterone, baseline LH and FSH levels, testicular function, treatment approach and individual response.

Enclomiphene has been shown in clinical trials to increase total testosterone in men with secondary hypogonadism while also increasing LH and FSH. It works by restoring signalling through the hypothalamic-pituitary-testicular axis.

hCG can also stimulate testosterone production by acting directly on LH receptors in the testes. Research shows that hCG can maintain or increase intratesticular testosterone, which is important for normal testicular function.

However, direct studies comparing enclomiphene with hCG are limited, so the evidence does not support saying that one consistently raises testosterone more than the other. Much of the available head-to-head research compares hCG with clomiphene, rather than enclomiphene specifically.

For that reason, the better option depends less on which treatment produces the highest number and more on why testosterone is low, how the hormonal pathway is functioning and what the treatment goals are.

Which Is Better for Preserving Fertility?

Both hCG and enclomiphene may have fertility-preserving roles, but neither is automatically the better option for every man. The choice depends on the cause of low testosterone, current sperm production, hormone levels and future fertility goals.

This is an important distinction from exogenous testosterone, which can suppress LH and FSH signalling and reduce sperm production. Men who want to maintain or restore fertility may therefore need a different treatment strategy.

Enclomiphene works by increasing the body’s own LH and FSH signalling. Clinical trials in men with secondary hypogonadism found that it increased testosterone while maintaining sperm concentrations, whereas exogenous testosterone reduced LH, FSH and sperm production.

hCG takes a different approach. It provides an LH-like signal directly to the testes, helping maintain intratesticular testosterone, which is important for spermatogenesis. It may therefore be used in fertility-focused treatment depending on the underlying hormonal problem.

For men who may want children in the future, fertility goals should be discussed before starting testosterone treatment so the treatment plan can account for reproductive health from the beginning.

How Do They Affect LH and FSH?

hCG and enclomiphene affect LH and FSH very differently, which is one of the most important distinctions between them.

hCG acts like LH rather than increasing the body’s own LH production. It binds to LH receptors in the testes and stimulates Leydig cells to produce testosterone. As testosterone and estrogen levels rise, normal hormonal feedback can reduce the pituitary gland’s own LH production.

Enclomiphene works upstream and tends to increase endogenous LH and FSH. By reducing estrogen-related negative feedback at the hypothalamic-pituitary level, it encourages the pituitary gland to release more of both hormones.

This difference matters for fertility because FSH plays a key role in spermatogenesis, or sperm production. FSH acts on Sertoli cells in the testes, while LH supports intratesticular testosterone production through Leydig cells. Both signals are important for normal sperm development.

For men concerned about fertility, looking at LH and FSH can therefore provide useful information about how the hormonal pathway is functioning and which treatment approach may be more appropriate.

Can hCG and Enclomiphene Help Maintain Testicular Function?

Both hCG and enclomiphene may help support testicular function, but they do so through different hormonal signals.

An important part of normal testicular function is maintaining intratesticular testosterone, meaning the concentration of testosterone inside the testes. This local testosterone level is much higher than the testosterone measured in the bloodstream and plays an important role in supporting sperm production.

hCG supports testicular signalling by acting like LH. It stimulates LH receptors on Leydig cells, which can help maintain intratesticular testosterone production. Research has shown that hCG can maintain intratesticular testosterone even when natural gonadotropin signalling is suppressed.

Enclomiphene works indirectly. By increasing the body’s own LH and FSH production, it helps preserve signalling between the pituitary gland and the testes. Clinical studies have shown increases in testosterone, LH and FSH while maintaining sperm production in men with secondary hypogonadism.

These effects do not guarantee preserved fertility or changes in testicular size. Individual response depends on the underlying cause of low testosterone, baseline testicular function and other fertility factors.

hCG vs Enclomiphene Administration

One of the most practical differences between hCG and enclomiphene is how they are taken.

hCG is administered by injection, while enclomiphene is taken orally. This difference may influence convenience, comfort and how easily someone follows their treatment plan.

Some men may prefer an oral treatment because it avoids injections, while others may be comfortable with injectable therapy. However, oral administration does not automatically make enclomiphene the better treatment.

The most appropriate option depends on factors such as the cause of low testosterone, fertility goals, hormone levels, treatment response and the ability to follow the prescribed regimen consistently.

Administration method is therefore one consideration, but it should not be the only factor used when choosing between hCG and enclomiphene.

What Are the Possible Side Effects?

Both hCG and enclomiphene can cause side effects, although the type and severity vary between individuals. Their different mechanisms also mean their side-effect profiles are not identical.

Possible Side Effects of hCG

Because hCG stimulates the testes to produce testosterone, it can also influence other hormone levels. Possible effects may include:

1. increased estradiol
2. breast tenderness or enlargement
3. acne or oily skin
4. fluid retention
5. mood changes
6. headache
7. injection-site discomfort

Not everyone experiences these effects, and the likelihood may depend on dose, hormone response and individual health factors. hCG is used in fertility-focused care because of its LH-like action and ability to stimulate endogenous testosterone production.

Possible Side Effects of Enclomiphene

Enclomiphene has generally been well tolerated in clinical studies, but possible side effects may include:

1. headache
2. nausea or gastrointestinal symptoms
3. changes in mood
4. hot flashes
5. changes in estradiol
6. visual symptoms in some patients

Because enclomiphene increases endogenous LH and FSH along with testosterone, its hormonal effects may differ from treatments that act directly at the testes. Clinical studies have shown increases in testosterone, LH and FSH in men with secondary hypogonadism.

Any persistent, severe or unexpected symptoms should be discussed with a healthcare provider rather than managed by changing treatment independently.

How Are hCG and Enclomiphene Monitored?

Monitoring is individualized and focuses on whether treatment is improving symptoms and producing an appropriate hormonal response without causing unwanted effects.

Depending on the treatment goal and individual health profile, monitoring may include:

1. Symptoms: Changes in energy, libido, sexual function and overall well-being.
2. Testosterone: Blood testing can show whether testosterone has increased into an appropriate range.
3. Estradiol: This may be checked when symptoms or hormone changes suggest it is relevant.
4. LH and FSH: Particularly useful with enclomiphene because these hormones help show how the pituitary-testicular pathway is responding.
5. Hematocrit: May be monitored when clinically appropriate because increasing testosterone can affect red blood cell production.
6. Semen analysis: When maintaining or improving fertility is an important treatment goal, semen testing can provide more useful information than testosterone levels alone.

Male fertility guidelines emphasize evaluating reproductive goals and using semen analysis when fertility is a concern.

There is no single monitoring schedule that is appropriate for every man. Testing depends on the reason for treatment, baseline hormone levels, fertility goals, symptoms and how the individual responds over time.

Who May Be a Better Candidate for hCG?

hCG may be considered for men who need more direct stimulation of the testes, particularly when fertility or maintaining testicular function is an important treatment goal.

Because hCG acts similarly to LH, it can stimulate Leydig cells in the testes even when the body’s own LH signalling is reduced. This can make it useful in certain forms of secondary hypogonadism, provided the testes are still capable of responding.

hCG may be considered when:

1. preserving or restoring fertility is an important goal
2. direct testicular stimulation is needed
3. LH signalling is insufficient but testicular function remains responsive
4. maintaining intratesticular testosterone is clinically important

Guidelines recognize hCG as one potential option for testosterone optimization in men with low or normal LH, particularly when fertility is a consideration.

Whether hCG is appropriate should be determined by a healthcare provider based on hormone testing, fertility goals and the underlying cause of low testosterone.

Who May Be a Better Candidate for Enclomiphene?

Enclomiphene may be better suited to some men with secondary or functional hypogonadism whose hypothalamic-pituitary-testicular axis is still capable of responding.

Enclomiphene works by encouraging the pituitary gland to produce more of the body’s own LH and FSH. Clinical trials in men with secondary hypogonadism have shown increases in testosterone, LH and FSH while maintaining sperm concentrations.

It may be considered when:

1. testosterone is low with low or inappropriately normal LH
2. the testes remain capable of responding to LH and FSH
3. maintaining endogenous hormonal signalling is a treatment goal
4. preserving fertility or sperm production is important

This distinction matters because enclomiphene depends on a functioning pituitary-testicular pathway. It would not be expected to work the same way in primary hypogonadism, where the testes themselves are unable to respond adequately to hormonal stimulation. Current guidance therefore distinguishes primary from secondary hypogonadism when considering treatments that stimulate endogenous testosterone production.

The choice should ultimately be individualized using symptoms, testosterone levels, LH and FSH results, fertility goals and overall clinical assessment.

Can hCG and Enclomiphene Be Used Together?

hCG and enclomiphene may sometimes be used as part of the same fertility or hormone-focused treatment strategy, but combining them is not automatically more effective than using either approach alone.

The rationale is that the two treatments act at different points in the hormonal pathway. Enclomiphene can increase the body’s own LH and FSH signalling, while hCG provides an additional LH-like signal directly to the testes.

However, evidence specifically studying the combination of enclomiphene and hCG is limited. Much of the available combination research involves hCG with clomiphene rather than enclomiphene. One randomized study found that clomiphene, hCG and their combination all increased testosterone, without demonstrating a clear testosterone advantage from combining them.

For that reason, using both together should be a clinician-directed decision based on hormone levels, fertility goals, testicular function and response to treatment rather than an assumption that more stimulation will produce better results.

Is hCG or Enclomiphene the Same as TRT?

No. hCG and enclomiphene are not the same as conventional TRT using exogenous testosterone.

Traditional TRT supplies testosterone from outside the body. This can suppress the hypothalamic-pituitary-testicular axis, reducing the body’s own LH and FSH production and potentially affecting sperm production.

hCG and enclomiphene instead aim to stimulate endogenous testosterone production:

1. hCG acts directly at the testes by providing an LH-like signal.
2. Enclomiphene acts upstream by encouraging the pituitary gland to release more of the body’s own LH and FSH. Clinical studies show that it can raise testosterone while maintaining gonadotropin signalling and sperm concentrations in men with secondary hypogonadism.

Terminology can vary in clinical practice, and these approaches may sometimes be discussed alongside testosterone therapy. However, they should not be treated as interchangeable with conventional TRT, because their mechanisms, effects on LH and FSH, fertility considerations and appropriate candidates are different.

Which Is Better: hCG or Enclomiphene?

Neither hCG nor enclomiphene is universally better. The more appropriate option depends on why testosterone is low, how the hormonal pathway is functioning and what the treatment goals are.

Important factors may include:

1. the underlying cause of low testosterone
2. LH and FSH levels
3. whether the testes are capable of responding normally
4. current and future fertility goals
5. whether maintaining endogenous hormone signalling is important
6. preference for injection versus oral treatment
7. individual response and side effects

hCG may be more appropriate when direct testicular stimulation is needed, while enclomiphene may be better suited to some men with secondary or functional hypogonadism whose pituitary-testicular pathway is still responsive.

The decision should be based on hormone testing, symptoms, fertility goals and clinician assessment rather than assuming one option is stronger or better for everyone.

When Should You Speak to a Healthcare Provider?

Speak to a healthcare provider if you have symptoms of low testosterone, fertility concerns or are considering hCG, enclomiphene or testosterone treatment.

A clinical assessment may be especially important if you have:

1. persistent low libido, fatigue or other symptoms of testosterone deficiency
2. low testosterone confirmed on blood testing
3. fertility plans now or in the future
4. abnormal LH or FSH results
5. difficulty conceiving
6. testicular problems or a history of testicular injury
7. pituitary or hormonal conditions
8. side effects or unexpected symptoms during treatment

The cause of low testosterone should be identified before choosing a treatment strategy. hCG, enclomiphene and conventional TRT work differently and are not interchangeable.

Do not start, combine, stop or change hormone treatment without guidance from a qualified healthcare provider.

Key Takeaways

1. hCG and enclomiphene can both support endogenous testosterone production, but they work differently.
2. hCG acts directly at the testes by providing an LH-like signal.
3. Enclomiphene works higher in the hormonal pathway and can increase the body’s own LH and FSH production.
4. Both may have fertility-preserving roles, but neither is universally better for every man.
5. The best option depends on the cause of low testosterone, LH and FSH levels, testicular function, fertility goals and individual response.
6. hCG is administered by injection, while enclomiphene is taken orally.
7. Neither hCG nor enclomiphene works the same way as conventional TRT using exogenous testosterone.
8. Treatment and monitoring should be individualized and clinician-guided.

FAQ

1. Is hCG better than enclomiphene?

Not necessarily. hCG and enclomiphene work through different mechanisms, and the better option depends on the cause of low testosterone, hormone levels, fertility goals and individual response.

2. Does enclomiphene work like hCG?

No. Enclomiphene encourages the pituitary gland to produce more LH and FSH, while hCG acts more directly at the testes by mimicking LH activity.

3. Can hCG increase testosterone?

Yes. hCG can stimulate Leydig cells in the testes to produce testosterone by activating LH receptors.

4. Can enclomiphene increase testosterone?

Yes. Enclomiphene can increase endogenous testosterone by stimulating the hormonal pathway that increases LH and FSH production.

5. Which is better for fertility, hCG or enclomiphene?

Neither is universally better. Both may be used in fertility-focused treatment, but the choice depends on sperm production, LH and FSH levels, testicular function and the underlying hormonal problem.

6. Does enclomiphene increase LH and FSH?

Yes. Enclomiphene can increase endogenous LH and FSH by reducing estrogen-related negative feedback at the hypothalamic-pituitary level.

7. Does hCG increase LH?

Not in the same way as enclomiphene. hCG acts like LH at receptors in the testes rather than increasing the body’s own LH production. Endogenous LH may remain low because of hormonal feedback.

8. Can hCG maintain sperm production?

hCG can help support intratesticular testosterone, which is important for spermatogenesis. However, maintaining sperm production is not guaranteed and may depend on other hormones and fertility factors.

9. Can enclomiphene maintain sperm production?

Clinical studies in men with secondary hypogonadism have shown that enclomiphene can increase testosterone while maintaining sperm concentrations. Individual fertility outcomes can still vary.

10. Can you take hCG and enclomiphene together?

They may sometimes be used together in clinician-directed fertility or hormone treatment strategies, but evidence specifically studying the combination is limited. Combining them is not automatically more effective.

11. Is enclomiphene the same as TRT?

No. Conventional TRT supplies testosterone from outside the body. Enclomiphene instead stimulates the body’s own hormonal signalling to increase endogenous testosterone production.

12. Is hCG the same as TRT?

No. hCG does not directly provide testosterone. It acts like LH and stimulates the testes to produce more of their own testosterone.